Literature DB >> 5095524

Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature.

J Bircher, U P Haemmerli, G Scollo-Lavizzari, K Hoffmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5095524     DOI： 10.1016/0002-9343(71)90233-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  13 in total

1.  Effect of vegetable and animal protein diets in chronic hepatic encephalopathy.

Authors:  N J Greenberger; J Carley; S Schenker; I Bettinger; C Stamnes; P Beyer
Journal:  Am J Dig Dis       Date:  1977-10

Review 2.  Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.

Authors:  G S Avery; E F Davies; R N Brogden
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  The many effects of lactulose: a rational approach to its therapeutic use.

Authors:  J Bircher
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 4.  Progress in the treatment of chronic portasystemic encephalopathy.

Authors:  I R Crossley; R Williams
Journal:  Gut       Date:  1984-01       Impact factor: 23.059

5.  Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study.

Authors:  F Orlandi; U Freddara; M T Candelaresi; A Morettini; G R Corazza; A Di Simone; G Dobrilla; G Cavallini
Journal:  Dig Dis Sci       Date:  1981-06       Impact factor: 3.199

Review 6.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Lise Lotte Gluud; Hendrik Vilstrup; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

7.  Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.

Authors:  C E Atterbury; W C Maddrey; H O Conn
Journal:  Am J Dig Dis       Date:  1978-05

8.  Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device.

Authors:  R L Bown; J A Gibson; G E Sladen; B Hicks; A M Dawson
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

9.  Binding of the ligand [3H]MK-801 to the MK-801 binding site of the N-methyl-D-aspartate receptor during experimental encephalopathy from acute liver failure and from acute hyperammonemia in the rabbit.

Authors:  R J de Knegt; J Kornhuber; S W Schalm; K Rusche; P Riederer; J Tan
Journal:  Metab Brain Dis       Date:  1993-06       Impact factor: 3.584

10.  Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics.

Authors:  L Agostini; P F Down; J Murison; O M Wrong
Journal:  Gut       Date:  1972-11       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.